Trial Profile
Effect of omalizumab on blood eosinophil (at 52 weeks) in subjects with severe asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 13 Jan 2016 New trial record